Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:2423-2427
Published online before print May 3, 2004, doi: 10.1161/01.CIR.0000129414.95137.CD
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/20/2423    most recent
01.CIR.0000129414.95137.CDv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lazar, R. M.
Right arrow Articles by Naka, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lazar, R. M.
Right arrow Articles by Naka, Y.
Related Collections
Right arrow Health policy and outcome research
Right arrow Congestive
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy
Right arrow Embolic stroke

(Circulation. 2004;109:2423-2427.)
© 2004 American Heart Association, Inc.


Clinical Investigation and Reports

Neurological Events During Long-Term Mechanical Circulatory Support for Heart Failure

The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Experience

Ronald M. Lazar, PhD; Peter A. Shapiro, MD; Brian E. Jaski, MD; Michael K. Parides, PhD; Robert C. Bourge, MD; John T. Watson, PhD; Laura Damme, RN, MPH; Walter Dembitsky, MD; Jeffrey D. Hosenpud, MD; Lopa Gupta, RD, MPH; Anita Tierney, MPH; Tonya Kraus, RN, MSN; Yoshifumi Naka, MD

From the Departments of Neurology (R.M.L.), Psychiatry (P.A.S.), Biostatistics (M.K.P.), and Surgery (L.G., A.T., Y.N.), Columbia University College of Physicians and Surgeons, New York, NY; the Advanced Heart Failure and Cardiac Transplant Program (B.E.J., W.D.), Sharp Memorial Hospital, San Diego, Calif; the Division of Cardiovascular Disease (R.C.B.), University of Alabama at Birmingham; the Department of Bioengineering (J.T.W.), University of California San Diego; Thoratec Corp, Pleasanton, Calif (L.D.); the Organ Transplant Program (J.E.H.), St Luke’s Medical Center, Milwaukee, Wis; and Inova Fairfax Hospital, Fairfax, Va (T.K.).

Correspondence to Dr R.M. Lazar, Neurological Institute, 710 W 168th Street, New York, NY 10032. E-mail ral22{at}columbia.edu

Received October 28, 2003; revision received February 19, 2004; accepted February 25, 2004.

Background— Progression of heart failure can lead to cardiac transplantation, but when patients are ineligible, long-term mechanical circulatory support may improve survival. The REMATCH trial showed that left ventricular assist devices (LVADs) prolonged survival in patients with end-stage disease, but with a significant number of adverse events. We report on the neurological outcomes in the REMATCH trial.

Methods and Results— We examined new neurological events in the 129 patients randomized to either LVAD placement (n=68) or medical management (n=61), classified as stroke, transient ischemic attack, toxic-metabolic encephalopathy, and other. There were 46 neurological events: 42 in 30 LVAD patients and 4 in 4 patients in the medical arm ({chi}2, 30/68 versus 4/61, P<0.001). Sixteen percent of the LVAD patients had a stroke, with a rate of 0.19 per year (95% CI, 0.10 to 0.33), many occurring in the postoperative period. The stroke rate in the medical arm was 0.052. A Kaplan-Meier survival analysis showed a 44% reduction in the risk of stroke or death in the LVAD group versus the optimal medical group (P=0.002). The mean interval from implantation to stroke was 221.8 days (±70.4 days). History of stroke, age, and sepsis were not stroke risk factors in the LVAD group.

Conclusions— Fewer than half of the patients in the LVAD group had a neurological event, and there were few neurological deaths. Survival analysis combining stroke or death demonstrated a significant benefit for long-term circulatory support with an LVAD over medical therapy. Future trials will need to address prospectively all neurological outcomes, including neurocognitive function, and the role of long-term neuroprotection.


Key Words: heart-assist device • stroke • heart failure




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
S. R. Wilson, M. M. Givertz, G. C. Stewart, and G. H. Mudge Jr
Ventricular assist devices the challenges of outpatient management.
J. Am. Coll. Cardiol., October 27, 2009; 54(18): 1647 - 1659.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Lietz, K. Brown, S. S. Ali, M. Colvin-Adams, A. J. Boyle, D. Anderson, A. D. Weinberg, L. W. Miller, S. Park, R. John, et al.
The role of cerebral hyperperfusion in postoperative neurologic dysfunction after left ventricular assist device implantation for end-stage heart failure
J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 1012 - 1019.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. W. Long, A. H. Healy, B. Y. Rasmusson, C. G. Cowley, K. E. Nelson, A. G. Kfoury, S. E. Clayson, B. B. Reid, S. A. Moore, D. U. Blank, et al.
Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
J. Thorac. Cardiovasc. Surg., June 1, 2008; 135(6): 1353 - 1361.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. G. Rogers, J. Butler, S. L. Lansman, A. Gass, P. M. Portner, M. K. Pasque, R. N. Pierson III, and for the INTrEPID Investigators
Chronic Mechanical Circulatory Support for Inotrope-Dependent Heart Failure Patients Who Are Not Transplant Candidates: Results of the INTrEPID Trial
J. Am. Coll. Cardiol., August 21, 2007; 50(8): 741 - 747.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. Tsukui, A. Abla, J. J. Teuteberg, D. M. McNamara, M. A. Mathier, L. M. Cadaret, and R. L. Kormos
Cerebrovascular accidents in patients with a ventricular assist device
J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 114 - 123.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. L. Steenwyk, J. K. Kirklin, W. Q. Gurley, and V. G. Nielsen
The Hemostatic History of a 15-Month-Old Child Implanted with a Berlin Heart Left Ventricular Assist Device
Anesth. Analg., March 1, 2007; 104(3): 538 - 540.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. W. Stevenson and P. Shekar
Ventricular Assist Devices for Durable Support
Circulation, August 30, 2005; 112(9): e111 - e115.
[Full Text] [PDF]


Home page
Evid. Based Med.Home page
Other articles noted
Evid. Based Med., September 1, 2004; 9(5): e5 - e5.
[Full Text] [PDF]